Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

181 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risks associated with the practice of traditional Chinese medicine: an Australian study.
Bensoussan A, Myers SP, Carlton AL. Bensoussan A, et al. Arch Fam Med. 2000 Nov-Dec;9(10):1071-8. doi: 10.1001/archfami.9.10.1071. Arch Fam Med. 2000. PMID: 11115210
OBJECTIVE: To investigate the nature and frequency of adverse events that occur as a result of the practice of traditional Chinese medicine (acupuncture and Chinese herbal medicine) in Australia. METHODS: Data on adverse events were obtained as part of a comprehensi …
OBJECTIVE: To investigate the nature and frequency of adverse events that occur as a result of the practice of traditional Chinese me …
Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C.
Batey RG, Bensoussan A, Fan YY, Bollipo S, Hossain MA. Batey RG, et al. Among authors: bensoussan a. J Gastroenterol Hepatol. 1998 Mar;13(3):244-7. doi: 10.1111/j.1440-1746.1998.01550.x. J Gastroenterol Hepatol. 1998. PMID: 9570235 Clinical Trial.
We report a study of a Chinese herbal medicine preparation CH-100 in the management of chronic hepatitis C. Patients with documented chronic hepatitis C were randomly allocated to receive active herbal or placebo tablets (five tablets thrice daily). Patients were fo …
We report a study of a Chinese herbal medicine preparation CH-100 in the management of chronic hepatitis C. Patients with docu …
Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.
Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Bensoussan A, et al. JAMA. 1998 Nov 11;280(18):1585-9. doi: 10.1001/jama.280.18.1585. JAMA. 1998. PMID: 9820260 Clinical Trial.
CONTEXT: Irritable bowel syndrome (IBS) is a common functional bowel disorder for which there is no reliable medical treatment. ...Patients received 5 capsules 3 times daily for 16 weeks and were evaluated regularly by a traditional Chinese herbalist and by a
CONTEXT: Irritable bowel syndrome (IBS) is a common functional bowel disorder for which there is no reliable medical treatment. ...Pa …
Complementary medicine. Searching for the evidence.
Bensoussan A. Bensoussan A. Aust Fam Physician. 2000 Dec;29(12):1129-33. Aust Fam Physician. 2000. PMID: 11140216
DISCUSSION: There are a large number of systematic reviews on complementary and alternative practices and many hundreds more randomised, controlled trials which form a growing body of original research. ...On the other hand, consumers are using these medicines and s …
DISCUSSION: There are a large number of systematic reviews on complementary and alternative practices and many hundreds more randomis …
Application of the general health status questionnaire SF36 to patients with gastrointestinal dysfunction: initial validation and validation as a measure of change.
Bensoussan A, Chang SW, Menzies RG, Talley NJ. Bensoussan A, et al. Aust N Z J Public Health. 2001;25(1):71-7. doi: 10.1111/j.1467-842x.2001.tb00554.x. Aust N Z J Public Health. 2001. PMID: 11297307 Clinical Trial.
OBJECTIVE: To determine whether the Short Form (SF36) Health Status Survey is a valid measure of health status and health change for patients with irritable bowel syndrome (IBS). METHODS: The SF36 was self-administered by 116 patients with IBS at the commencement and end o …
OBJECTIVE: To determine whether the Short Form (SF36) Health Status Survey is a valid measure of health status and health change for …
Establishing evidence for Chinese medicine: a case example of irritable bowel syndrome.
Bensoussan A. Bensoussan A. Zhonghua Yi Xue Za Zhi (Taipei). 2001 Sep;64(9):487-92. Zhonghua Yi Xue Za Zhi (Taipei). 2001. PMID: 11768276 Review.
A clinical trial was designed using a variety of approaches to promote methodological rigour whilst allowing the flexibility required in TCM practice. ...Patients were randomised to receive individually tailored treatment (n = 38), a standard Chinese herbal f
A clinical trial was designed using a variety of approaches to promote methodological rigour whilst allowing the flexibility r
Development of a Chinese herbal medicine toxicology database.
Bensoussan A, Myers SP, Drew AK, Whyte IM, Dawson AH. Bensoussan A, et al. J Toxicol Clin Toxicol. 2002;40(2):159-67. doi: 10.1081/clt-120004404. J Toxicol Clin Toxicol. 2002. PMID: 12126187 Review.
The goals of this project were to retrieve and evaluate scientific evidence on the toxicity of Chinese herbal medicine, to grade the toxicity of individual herbs, and to summarize relevant herb data via a searchable electronic database. ...Twelve herb monographs (with a
The goals of this project were to retrieve and evaluate scientific evidence on the toxicity of Chinese herbal medicine, to grade the toxicit …
Chinese herbal medicine toxicology database: monograph on Herba Asari, "xi xin".
Drew AK, Whyte IM, Bensoussan A, Dawson AH, Zhu X, Myers SP. Drew AK, et al. Among authors: bensoussan a. J Toxicol Clin Toxicol. 2002;40(2):169-72. doi: 10.1081/clt-120004405. J Toxicol Clin Toxicol. 2002. PMID: 12126188 Review. No abstract available.
Chinese herbal medicine toxicology database: monograph on Radix Sophorae Flavescentis, "ku shen".
Drew AK, Bensoussan A, Whyte IM, Dawson AH, Zhu X, Myers SP. Drew AK, et al. Among authors: bensoussan a. J Toxicol Clin Toxicol. 2002;40(2):173-6. doi: 10.1081/clt-120004406. J Toxicol Clin Toxicol. 2002. PMID: 12126189 Review. No abstract available.
Regulation of complementary medicine practitioners in Australia: Chinese medicine as a case example.
Carlton AL, Bensoussan A. Carlton AL, et al. Among authors: bensoussan a. Complement Ther Med. 2002 Mar;10(1):20-6. doi: 10.1054/ctim.2002.0521. Complement Ther Med. 2002. PMID: 12442819 Review.
Complementary and alternative medicine (CAM) forms a significant part of the health economy. CAM practices are under increased scrutiny from consumers, clinicians, scientists and regulators. Australian authorities have explored a range of regulatory approaches. This …
Complementary and alternative medicine (CAM) forms a significant part of the health economy. CAM practices are under increased scruti …
181 results
Jump to page
Feedback